Literature DB >> 18617749

Experimental rhinovirus infection increases human tissue kallikrein activation in allergic subjects.

Sandra C Christiansen1, Jane Eddleston, Sara H Bengtson, Gavin R Jenkins, Robert B Sarnoff, Ronald B Turner, Jack M Gwaltney, Bruce L Zuraw.   

Abstract

BACKGROUND: Rhinovirus infection is a major cause of asthma exacerbations. While rhinovirus infection is known to generate kinins in the upper respiratory track, little is known about the effect of rhinovirus on kinin generation in the lower airway. We previously identified human tissue kallikrein (hTK) as the principal lung kininogenase during allergic airway inflammation. In this report we investigate the effect of experimental rhinovirus infection on hTK activity in the airways of atopic subjects with and without asthma.
METHODS: Eight atopic subjects, 4 with asthma, underwent bronchoscopy with lavage. At least 1 month later, subjects were inoculated with rhinovirus, then underwent repeat bronchoscopy with lavage 4 and 18 days later. hTK mRNA was measured in nasal scrape samples by quantitative real-time PCR. hTK activity (chromogenic substrate assay) and IL-8 levels (ELISA) were assessed in the bronchoalveolar lavage fluid.
RESULTS: At day 4 after rhinovirus inoculation, nasal hTK mRNA was modestly increased in both the rhinitis (1.7-fold) and asthmatic (2.1-fold) groups. A doubling or greater increase in hTK activity after rhinovirus infection was observed in all 4 asthmatic subjects (mean 19-fold increase) but only in 1 of 4 atopic subjects without asthma (mean 2-fold increase). Rhinovirus infection also increased the IL-8 protein level in bronchoalveolar lavage fluid, which correlated with hTK activity (R = 0.82).
CONCLUSION: Experimental rhinovirus infection in allergic asthmatic subjects is accompanied by increased lower airway hTK activation, which parallels the appearance of IL-8. Rhinovirus-induced hTK activation may contribute to airway inflammation and asthmatic exacerbations. 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18617749     DOI: 10.1159/000144037

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  9 in total

1.  Human airway smooth muscle cells secrete amphiregulin via bradykinin/COX-2/PGE2, inducing COX-2, CXCL8, and VEGF expression in airway epithelial cells.

Authors:  Karl Deacon; Alan J Knox
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-06-05       Impact factor: 5.464

Review 2.  Unleashing the therapeutic potential of human kallikrein-related serine proteases.

Authors:  Ioannis Prassas; Azza Eissa; Gennadiy Poda; Eleftherios P Diamandis
Journal:  Nat Rev Drug Discov       Date:  2015-02-20       Impact factor: 84.694

3.  Rhinovirus C15 Induces Airway Hyperresponsiveness via Calcium Mobilization in Airway Smooth Muscle.

Authors:  Vishal Parikh; Jacqueline Scala; Riva Patel; Corinne Corbi; Dennis Lo; Yury A Bochkov; Joshua L Kennedy; Richard C Kurten; Stephen B Liggett; James E Gern; Cynthia J Koziol-White
Journal:  Am J Respir Cell Mol Biol       Date:  2020-03       Impact factor: 6.914

4.  Kallistatin ameliorates influenza virus pathogenesis by inhibition of kallikrein-related peptidase 1-mediated cleavage of viral hemagglutinin.

Authors:  Chia-Hsing Leu; Mei-Lin Yang; Nai-Hui Chung; Yen-Jang Huang; Yu-Chu Su; Yi-Cheng Chen; Chia-Cheng Lin; Gia-Shing Shieh; Meng-Ya Chang; Shainn-Wei Wang; Yao Chang; Julie Chao; Lee Chao; Chao-Liang Wu; Ai-Li Shiau
Journal:  Antimicrob Agents Chemother       Date:  2015-07-06       Impact factor: 5.191

Review 5.  Pathogenesis of rhinovirus infection.

Authors:  Joshua L Kennedy; Ronald B Turner; Thomas Braciale; Peter W Heymann; Larry Borish
Journal:  Curr Opin Virol       Date:  2012-04-27       Impact factor: 7.090

6.  COVID-19 and hereditary angioedema: Incidence, outcomes, and mechanistic implications.

Authors:  Camila Lopes Veronez; Sandra C Christiansen; Tukisa D Smith; Marc A Riedl; Bruce L Zuraw
Journal:  Allergy Asthma Proc       Date:  2021-11-01       Impact factor: 2.587

Review 7.  Utility of animal and in vivo experimental infection of humans with rhinoviruses in the development of therapeutic agents for viral exacerbations of asthma and chronic obstructive pulmonary disease.

Authors:  Alfred M Del Vecchio; Patrick J Branigan; Elliot S Barnathan; Susan K Flavin; Philip E Silkoff; Ronald B Turner
Journal:  Pulm Pharmacol Ther       Date:  2014-11-13       Impact factor: 3.410

Review 8.  Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets.

Authors:  Masoumeh Farahani; Zahra Niknam; Leila Mohammadi Amirabad; Nasrin Amiri-Dashatan; Mehdi Koushki; Mohadeseh Nemati; Fahima Danesh Pouya; Mostafa Rezaei-Tavirani; Yousef Rasmi; Lobat Tayebi
Journal:  Biomed Pharmacother       Date:  2021-11-12       Impact factor: 7.419

9.  Lung epithelial cells have virus-specific and shared gene expression responses to infection by diverse respiratory viruses.

Authors:  James T VanLeuven; Benjamin J Ridenhour; Andres J Gonzalez; Craig R Miller; Tanya A Miura
Journal:  PLoS One       Date:  2017-06-02       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.